...
首页> 外文期刊>Clinical oral implants research >Bone formation with a biphasic calcium phosphate combined with fibrin sealant in maxillary sinus floor elevation for delayed dental implant
【24h】

Bone formation with a biphasic calcium phosphate combined with fibrin sealant in maxillary sinus floor elevation for delayed dental implant

机译:双相磷酸钙结合血纤蛋白封闭剂在上颌窦底抬高中形成骨,用于延迟种植牙

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: The aim of this study was to evaluate the extent and quality of new bone 6 months after sinus lift with biphasic micro- and macroporous calcium phosphate combined with fibrin sealant (MBCP-FS) and the 1-year implant success rate in the augmented site. Material and methods: MBCP-FS was applied to one sinus in 96 subjects requiring augmentation for delayed dental implant placement. In subjects who required bilateral lifts (N = 33), the MBCP-FS sinus was randomly selected; the contralateral sinus was grafted with autologous bone (mixed with Bio-Oss when harvested bone volume was insufficient. Panoramic views were taken periodically prior to and up to 18 months post-lift. Histomorphometric analysis was conducted on biopsies taken during implant placement 6 months after augmentation. Implant functionality and prosthesis success were assessed clinically 1 year after implant placement. Results: In MBCP-FS sinuses, 20.6 ± 8.5% new, mainly lamellar bone was observed. Implants were placed as planned in 78/85 evaluable subjects (91.8%) 6 months after sinus lift. Graft heights remained stable 1 year after placement; 94.7% (142/150) of implants were functional. The amount and quality of new bone and implant success rates with MBCP-FS were similar to autologous bone graft (mixed with Bio-Oss in 30/31 evaluable subjects). MBCP-FS was safe and well-tolerated. Conclusions: MBCP-FS is safe and effective in sinus floor elevation for dental implant placement, supporting bone regeneration and with high 1-year implant success rates similar to autologous bone mixed with Bio-Oss.
机译:目的:本研究的目的是评估双相微孔和大孔磷酸钙结合纤维蛋白封闭剂(MBCP-FS)提窦后6个月新骨的范围和质量,以及增强后1年的成功率现场。材料和方法:MBCP-FS应用于96位需要扩大种植体以延迟种植牙的受试者中的一个鼻窦。在需要双侧举升(N = 33)的受试者中,MBCP-FS鼻窦是随机选择的。将对侧窦移植自体骨(当收获的骨量不足时与Bio-Oss混合。在提拉前和提拉后18个月内定期进行全景观察。对植入物放置后6个月进行的活组织检查进行组织形态计量学分析结果:在MBCP-FS鼻窦中,观察到20.6±8.5%的新骨,主要是层状骨,按计划在78/85位可评估的受试者中进行了植入(91.8%)。 )鼻窦抬高后6个月。植入后1年,移植高度保持稳定; 94.7%(142/150)的植入物起作用,MBCP-FS的新骨数量和质量以及植入成功率与自体骨移植相似(在30/31个可评估的受试者中与Bio-Oss混合使用)MBCP-FS安全且耐受性良好结论:MBCP-FS安全有效地用于种植牙种植体的窦底抬高,支持骨再生,并具有很高的1年植入成功率,类似于自体骨与Bio-Oss混合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号